GMED Globus Medical Inc

Price (delayed)

$62.50

Market cap

$6.24B

P/E Ratio

60.1

Dividend/share

N/A

EPS

$1.04

Enterprise value

$6B

Sector: Healthcare
Industry: Medical Devices

Highlights

GMED's equity is up by 7% year-on-year and by 6% since the previous quarter
Globus Medical's revenue has increased by 2.8% QoQ
The company's net income fell by 34% YoY but it rose by 8% QoQ
The EPS has declined by 34% year-on-year but it has grown by 8% since the previous quarter
The P/E is 79% more than the 5-year quarterly average of 33.5 and 23% more than the last 4 quarters average of 48.9
GMED's gross margin is down by 6% year-on-year

Key stats

What are the main financial stats of GMED
Market
Shares outstanding
99.8M
Market cap
$6.24B
Enterprise value
$6B
Valuations
Price to earnings (P/E)
60.1
Price to book (P/B)
4.09
Price to sales (P/S)
7.81
EV/EBIT
53.58
EV/EBITDA
34.31
EV/Sales
7.6
Earnings
Revenue
$789.04M
EBIT
$111.95M
EBITDA
$174.82M
Free cash flow
$135.14M
Per share
EPS
$1.04
Free cash flow per share
$1.37
Book value per share
$15.27
Revenue per share
$8
TBVPS
$14.57
Balance sheet
Total assets
$1.68B
Total liabilities
$173.19M
Debt
$0
Equity
$1.51B
Working capital
$700.97M
Liquidity
Debt to equity
0
Current ratio
6.8
Quick ratio
4.71
Net debt/EBITDA
-1.37
Margins
EBITDA margin
22.2%
Gross margin
72.4%
Net margin
13%
Operating margin
14.1%
Efficiency
Return on assets
6.6%
Return on equity
7.3%
Return on invested capital
11.1%
Return on capital employed
7.2%
Return on sales
14.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

GMED stock price

How has the Globus Medical stock price performed over time
Intraday
0.84%
1 week
-1.95%
1 month
-1.39%
1 year
26.65%
YTD
-4.17%
QTD
-4.17%

Financial performance

How have Globus Medical's revenue and profit performed over time
Revenue
$789.04M
Gross profit
$571.58M
Operating income
$111.43M
Net income
$102.29M
Gross margin
72.4%
Net margin
13%
The company's operating margin fell by 36% YoY but it rose by 5% QoQ
The operating income has decreased by 35% YoY but it has increased by 8% QoQ
The net margin has declined by 34% year-on-year but it has increased by 4.8% since the previous quarter
The company's net income fell by 34% YoY but it rose by 8% QoQ

Growth

What is Globus Medical's growth rate over time

Valuation

What is Globus Medical stock price valuation
P/E
60.1
P/B
4.09
P/S
7.81
EV/EBIT
53.58
EV/EBITDA
34.31
EV/Sales
7.6
The P/E is 79% more than the 5-year quarterly average of 33.5 and 23% more than the last 4 quarters average of 48.9
The EPS has declined by 34% year-on-year but it has grown by 8% since the previous quarter
The stock's P/B is 14% more than its 5-year quarterly average of 3.6 and 14% more than its last 4 quarters average of 3.6
GMED's equity is up by 7% year-on-year and by 6% since the previous quarter
GMED's P/S is 32% higher than its 5-year quarterly average of 5.9 and 20% higher than its last 4 quarters average of 6.5
Globus Medical's revenue has increased by 2.8% QoQ

Efficiency

How efficient is Globus Medical business performance
The ROA is down by 39% year-on-year but it is up by 4.8% since the previous quarter
Globus Medical's return on equity has decreased by 38% YoY but it has increased by 6% QoQ
GMED's ROIC is down by 37% year-on-year but it is up by 8% since the previous quarter
The return on sales has declined by 35% year-on-year but it has grown by 6% since the previous quarter

Dividends

What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GMED.

Financial health

How did Globus Medical financials performed over time
The company's total liabilities rose by 39% QoQ and by 34% YoY
Globus Medical's current ratio has decreased by 16% QoQ but it has increased by 10% YoY
The debt is 100% smaller than the equity
GMED's equity is up by 7% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.